The Latent Benefits of Publication Bias
This article was originally published in RPM Report
While some assume there are "unethical" motives behind publication bias in the journal system, there are some meaningful benefits for researchers.
You may also be interested in...
GlaxoSmithKline's diabetes drug Avandia survived a perilous FDA advisory committee review. The real question is whether the industry can survive the damage to FDA's credibility.